The size of the Global Protein Therapeutics market was around USD 159.93 billion in 2018. It is expected to grow at a CAGR of 6.5% to reach USD 219.12 billion by 2023.
Protein therapeutics are most often employed in the treatment of chronic ailments like cancer etc. This market has a huge potential in the coming years.
An increasing number of people suffering from chronic diseases coupled with rapid advancements in the medical sciences resulting in the development of plasma-based therapies are driving the growth of this market.
On the other hand, vague government policies and cumbersome administrative framework conjoined with the heavy cost of this treatment are inhibiting the market growth.
Market Size Available
2018 – 2024
2019 - 2024
By Product, Application, Therapeutic Modalities, Region
Various Analyses Covered
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities
North America, Europe, APAC, Latin America, Middle East & Africa
Market Leaders Profiled
Baxter International Inc., Eli Lilly and Company, Abbott Laboratories, Amgen Inc., F. Hoffmann-La Roche Ltd. Other players in the market are Novo Nordisk A/S, Pfizer Inc., Johnson & Johnson, Merck & Co., Inc., and Sanofi.
This market research report on the Global Protein Therapeutics Market has been segmented and sub-segmented into the following categories and analyzed market size and forecast until 2024.
Protein Therapeutics Market Analysis - By Product
On the basis of product, in 2018, Monoclonal antibodies captured the largest market share. It is projected to remain the top leading segment in the forecast period. It is also the market sub-segment which is anticipated to undergo the fastest growth till 2024.
Protein Therapeutics Market Analysis - By Application
On the basis of application, in 2016, metabolic disorders accounted for the highest market share. However, the cancer market sub-category is predicted to grow the fastest in the forecast period.
Protein Therapeutics Market Analysis - By Therapeutic Modalities
Protein Therapeutics Market Analysis – By Region
North America raked in the highest revenue in 2016. This trend is likely to continue in the forecast period. However, growing awareness about these novel treatment methods in the emerging economies makes it likely that Asia Pacific will grow with the highest CAGR in the forecast period.
Top companies in the market
Key players in the market are Baxter International Inc., Eli Lilly and Company, Abbott Laboratories, Amgen Inc., F. Hoffmann-La Roche Ltd. Other players in the market are Novo Nordisk A/S, Pfizer Inc., Johnson & Johnson, Merck & Co., Inc., and Sanofi.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1.2 Monoclonal Antibodies
5.1.4 Fusion Protein
5.1.7 Human Growth Hormone
5.1.8 Follicle Stimulating Hormone
5.1.9 Y-o-Y Growth Analysis, By Product
5.1.10 Market Attractiveness Analysis, By Product
5.1.11 Market Share Analysis, By Product
5.2 Therapeutic Modalities
5.2.2 Protein diagnostics
5.2.3 Protein vaccines
5.2.4 Protein therapeutics with special targeting activity
5.2.5 Protein therapeutics with enzymatic or regulatory activity
5.2.6 Y-o-Y Growth Analysis, By Therapeutic Modalities
5.2.7 Market Attractiveness Analysis, By Therapeutic Modalities
5.2.8 Market Share Analysis, By Therapeutic Modalities
5.3.2 Metabolic Disorders
5.3.3 Immunologic Disorders
5.3.4 Hematological Disorders
5.3.6 Hormonal Disorders
5.3.7 Genetic Disorders
5.3.9 Y-o-Y Growth Analysis, By Application
5.3.10 Market Attractiveness Analysis, By Application
5.3.11 Market Share Analysis, By Application
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
184.108.40.206 By Geographical Area
220.127.116.11 By Product
18.104.22.168 By Therapeutic Modalities
22.214.171.124 By Application
6.1.4 Market Attractiveness Analysis
126.96.36.199 By Geographical Area
188.8.131.52 By Product
184.108.40.206 By Therapeutic Modalities
220.127.116.11 By Application
6.1.5 Market Share Analysis
18.104.22.168 By Geographical Area
22.214.171.124 By Product
126.96.36.199 By Therapeutic Modalities
188.8.131.52 By Application
6.2 North America
6.1.2 United States
6.3.6 South Korea
6.5 Latin America
6.4.5 Rest of Latin America
6.6 Middle East & Africa
7. Strategic Analysis
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Abbott Laboratories
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Amgen Inc.
8.3 Baxter International Inc.
8.4 Eli Lilly and Company
8.5 F. Hoffmann-La Roche Ltd.
8.6 Johnson & Johnson
8.7 Merck & Co. Inc.
8.8 Novo Nordisk A/S
8.9 Pfizer Inc.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures